Metabolic Check-up : Longevity & Anti-Aging Blood Test with Nutritionist in Zurich & Geneva

LDL cholesterol has been the standard measure of cardiovascular risk for decades. But the science has moved significantly beyond it. ApoB is now recognized by leading cardiologists and preventive medicine specialists as the single most accurate predictor of atherosclerosis and coronary artery disease. Here is the critical difference. LDL measures the concentration of cholesterol contained within LDL particles. ApoB counts the actual number of atherogenic particles circulating in your arteries, each of which carries exactly one ApoB molecule. Particle number, not cholesterol concentration, is what determines how much damage is being done to arterial walls. Two people can have identical LDL cholesterol with very different ApoB levels, and therefore very different true cardiovascular risk. A high ApoB level, even with a normal LDL, signals an elevated risk that standard lipid testing would miss entirely.

The complete lipid profile provides the clinical foundation of cardiovascular risk assessment and gives context to the ApoB result. Triglycerides are particularly informative. Elevated triglycerides are closely linked to insulin resistance and metabolic syndrome, and they are one of the most sensitive dietary markers in the panel. A drop in triglycerides following nutritional intervention is one of the earliest measurable signs that metabolic health is improving.

Together, these two markers reveal the complete picture of glucose metabolism and insulin sensitivity. HbA1c captures average blood sugar over three months, a window that a single fasting glucose measurement cannot provide. The HOMA index quantifies insulin resistance directly, using fasting glucose and fasting insulin together. Insulin resistance is the metabolic root condition that drives abdominal fat accumulation, cognitive decline, chronic inflammation, elevated triglycerides, and accelerated cellular aging, typically for many years before blood sugar levels become abnormal enough to generate any clinical concern. Early detection through a metabolic blood test in Zurich is the difference between a dietary correction and a decade of progressive metabolic damage.

Chronic cortisol elevation is a powerful and under-appreciated driver of metabolic dysfunction. Sustained high cortisol promotes visceral fat storage specifically around the abdomen, suppresses immune function, elevates blood sugar, and drives systemic inflammation. A single morning cortisol measurement provides a clear snapshot of the adrenal stress response and flags whether chronic stress is actively accelerating your metabolic aging.

Thyroid function governs the speed of virtually every metabolic process in the body. Even subclinical hypothyroidism, which does not yet meet the clinical threshold for a diagnosis, measurably elevates LDL cholesterol, slows metabolic rate, increases cardiovascular risk, and impairs cognitive performance. For a longevity-focused panel, TSH provides the essential metabolic baseline.

The liver regulates cholesterol synthesis, clears metabolic waste, metabolizes hormones, and manages the inflammatory response. Liver enzyme elevation, even at levels well within the broad clinical reference ranges, is a sensitive early marker of metabolic stress. GGT in particular has been identified in research as an independent predictor of cardiovascular and metabolic risk beyond its traditional role as a liver function marker.

Iron stores are increasingly studied in the context of cardiovascular and metabolic health beyond their classical role in energy and haemoglobin production. Elevated ferritin is an independent marker of systemic inflammation and a component of metabolic syndrome in a significant proportion of affected individuals. Iron stores that are too high, not just too low, can be clinically relevant in this context.

Vitamin D deficiency is associated with increased cardiovascular risk, insulin resistance, impaired immune function, cognitive decline, and accelerated biological aging. In Switzerland, vitamin D insufficiency is extremely prevalent, affecting a significant majority of adults during autumn and winter months. In the context of a longevity panel, vitamin D is not simply a nutritional marker. It is a metabolic and immunological one.

Standard CRP detects acute inflammation from infection or injury. High-sensitivity CRP is a different measurement that detects the low-grade, chronic, systemic inflammation that produces no obvious symptoms but silently damages blood vessels, brain tissue, and metabolic organs over years. Research consistently identifies elevated hsCRP as one of the strongest independent predictors of cardiovascular events and metabolic disease. It is a direct measure of the inflammatory environment in which your cells are aging.

Follicle-Stimulating Hormone rises as ovarian function declines, making it the most reliable early marker of the perimenopausal transition. But this transition is far more than a reproductive event. It is a metabolic inflection point. The progressive decline in oestrogen that accompanies rising FSH directly increases cardiovascular risk, accelerates bone mineral loss, alters insulin sensitivity, and affects cognitive function and mood. For women under 50, FSH provides critical context for interpreting the entire Metabolic Check-up and allows the nutritionist to design a plan specifically adapted to the hormonal and metabolic changes of perimenopause.